Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.

News > Research buzz > Cystic fibrosis drug trialled to fight inflammation caused by COVID-19

Cystic fibrosis drug trialled to fight inflammation caused by COVID-19

Patients with COVID-19 will be given the drug 'Dornase alfa' to determine if it can help improve survival by reducing excess inflammation in the lungs, as part of a trial at UCL and the Crick..
6 Aug 2020
United Kingdom
Research buzz

To view this News Article please log in or create a profile

Similar stories

Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their own electric network, like that seen in the body’s ner… More...

Researchers from the Crick and Barts have shown that a genetic fault long believed to drive the development of oesophage… More...

Researchers at the Crick, MRC Harwell Institute and UCL Queen Square Institute of Neurology have identified the genetic … More...

Colleagues have generated human stem cell models which, for the first time, contain notochord – a tissue in the developi… More...

Have your say

 
image

Contact us

The Francis Crick Institute
1 Midland Road
London
NW1 1AT

connect@crick.ac.uk